Afficher la notice abrégée

dc.creatorEleftheriadis T., Makri P., Karakosta P., Pissas G., Liakopoulos V., Michelakakis H., Hadjigeorgiou G.M., Stefanidis I.en
dc.date.accessioned2023-01-31T07:37:12Z
dc.date.available2023-01-31T07:37:12Z
dc.date.issued2018
dc.identifier10.1111/hdi.12617
dc.identifier.issn14927535
dc.identifier.urihttp://hdl.handle.net/11615/71312
dc.description.abstractA 37-year-old hemodialysis patient appeared with unusual somnolence during 2 successive hemodialysis sessions. Blood gas analysis revealed hypercapnic respiratory failure and spirometry restrictive lung disease. After exclusion of other causes of restrictive lung disease with chest CT-scan and cerebrum MRI, electrophysiological study revealed myopathy. Because besides lordosis and limb-girdle gait the patient was ambulant the possibility of late-onset Pompe's disease was set and confirmed with evaluation of α-glucosidase activity and genetic analysis. Enzyme replacement therapy (ERT) with aglucosidase alfa was started. Due to inaccessibility of veins in the arm without the arteriovenous fistula, during the last 1 year, the patient received the ERT through the venous line of the hemodialysis circuit. Three years later the patient remains ambulant without the need of any assistant device and preserved his pulmonary function. This is the first described case of late-onset Pompe's disease in a hemodialysis patient treated with ERT. © 2017 International Society for Hemodialysisen
dc.language.isoenen
dc.sourceHemodialysis Internationalen
dc.source.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85045083415&doi=10.1111%2fhdi.12617&partnerID=40&md5=de013cae48514770a00637d6f6dcd1ed
dc.subjectalpha glucosidaseen
dc.subjectcreatine kinaseen
dc.subjectrecombinant glucan 1,4 alpha glucosidaseen
dc.subjectadulten
dc.subjectArticleen
dc.subjectbilevel positive airway pressureen
dc.subjectblood gas analysisen
dc.subjectcase reporten
dc.subjectclinical articleen
dc.subjectcreatine kinase blood levelen
dc.subjectdisease associationen
dc.subjectelectronic medical recorden
dc.subjectend stage renal diseaseen
dc.subjectenzyme activityen
dc.subjectenzyme replacementen
dc.subjectforced expiratory volumeen
dc.subjectforced vital capacityen
dc.subjectgenetic analysisen
dc.subjectglycogen storage disease type 2en
dc.subjecthemodiafiltrationen
dc.subjecthemodialysisen
dc.subjectheterozygoteen
dc.subjecthospital dischargeen
dc.subjecthumanen
dc.subjecthypertensionen
dc.subjectimmunoglobulin A nephropathyen
dc.subjectlate onset Pompe diseaseen
dc.subjectlordosisen
dc.subjectmaleen
dc.subjectmyopathyen
dc.subjectnerve conductionen
dc.subjectnoninvasive ventilationen
dc.subjectphysical examinationen
dc.subjectpolymerase chain reactionen
dc.subjectpositive end expiratory pressureen
dc.subjectprimary biliary cirrhosisen
dc.subjectrespiratory failureen
dc.subjectspirometryen
dc.subjectstenosisen
dc.subjectglycogen storage disease type 2en
dc.subjecthemodialysisen
dc.subjectpathologyen
dc.subjectAdulten
dc.subjectGlycogen Storage Disease Type IIen
dc.subjectHumansen
dc.subjectMaleen
dc.subjectRenal Dialysisen
dc.subjectBlackwell Publishing Inc.en
dc.titleLate-onset Pompe's disease in a hemodialysis patient: A first case reporten
dc.typejournalArticleen


Fichier(s) constituant ce document

FichiersTailleFormatVue

Il n'y a pas de fichiers associés à ce document.

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée